1119 related articles for article (PubMed ID: 18295562)
41. [Direct bone morphogenetic protein 2 gene therapy for repairing segmental radial defect in rabbits].
Li J; Bai L; Sun H; Han D; Gu J; Wang H; Duan J; Xu X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Sep; 19(9):725-8. PubMed ID: 16206762
[TBL] [Abstract][Full Text] [Related]
42. The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects.
Hong SJ; Kim CS; Han DK; Cho IH; Jung UW; Choi SH; Kim CK; Cho KS
Biomaterials; 2006 Jul; 27(20):3810-6. PubMed ID: 16574220
[TBL] [Abstract][Full Text] [Related]
43. Comparative effects of bone morphogenetic proteins and sox9 overexpression on extracellular matrix metabolism of bovine nucleus pulposus cells.
Zhang Y; An HS; Thonar EJ; Chubinskaya S; He TC; Phillips FM
Spine (Phila Pa 1976); 2006 Sep; 31(19):2173-9. PubMed ID: 16946650
[TBL] [Abstract][Full Text] [Related]
44. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum- and fat-derived cells.
Park J; Gelse K; Frank S; von der Mark K; Aigner T; Schneider H
J Gene Med; 2006 Jan; 8(1):112-25. PubMed ID: 16142704
[TBL] [Abstract][Full Text] [Related]
45. Converse relationship between in vitro osteogenic differentiation and in vivo bone healing elicited by different populations of muscle-derived cells genetically engineered to express BMP4.
Peng H; Usas A; Gearhart B; Olshanski A; Shen HC; Huard J
J Bone Miner Res; 2004 Apr; 19(4):630-41. PubMed ID: 15005851
[TBL] [Abstract][Full Text] [Related]
46. Repair of an intercalated long bone defect with a synthetic biodegradable bone-inducing implant.
Yoneda M; Terai H; Imai Y; Okada T; Nozaki K; Inoue H; Miyamoto S; Takaoka K
Biomaterials; 2005 Sep; 26(25):5145-52. PubMed ID: 15792541
[TBL] [Abstract][Full Text] [Related]
47. Bone regeneration after topical BMP-2-gene delivery in circumferential peri-implant bone defects.
Lutz R; Park J; Felszeghy E; Wiltfang J; Nkenke E; Schlegel KA
Clin Oral Implants Res; 2008 Jun; 19(6):590-9. PubMed ID: 18422983
[TBL] [Abstract][Full Text] [Related]
48. Bone formation following transplantation of genetically modified primary bone marrow stromal cells.
Sugiyama O; Orimo H; Suzuki S; Yamashita K; Ito H; Shimada T
J Orthop Res; 2003 Jul; 21(4):630-7. PubMed ID: 12798062
[TBL] [Abstract][Full Text] [Related]
49. The effect on bone regeneration of a liposomal vector to deliver BMP-2 gene to bone grafts in peri-implant bone defects.
Park J; Lutz R; Felszeghy E; Wiltfang J; Nkenke E; Neukam FW; Schlegel KA
Biomaterials; 2007 Jun; 28(17):2772-82. PubMed ID: 17339051
[TBL] [Abstract][Full Text] [Related]
50. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells.
Kuroda R; Usas A; Kubo S; Corsi K; Peng H; Rose T; Cummins J; Fu FH; Huard J
Arthritis Rheum; 2006 Feb; 54(2):433-42. PubMed ID: 16447218
[TBL] [Abstract][Full Text] [Related]
51. [Effects of bone morphogenetic protein-2 gene therapy on the bone-implant interface: an experimental study with dogs].
Yan MN; Tang TT; Zhu ZA; Zhou XS; Jia QW; Yu CF; Lou JR; Dai KR
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1521-5. PubMed ID: 16179108
[TBL] [Abstract][Full Text] [Related]
52. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis.
Scharstuhl A; Vitters EL; van der Kraan PM; van den Berg WB
Arthritis Rheum; 2003 Dec; 48(12):3442-51. PubMed ID: 14673995
[TBL] [Abstract][Full Text] [Related]
53. Bone regeneration by implantation of adipose-derived stromal cells expressing BMP-2.
Li H; Dai K; Tang T; Zhang X; Yan M; Lou J
Biochem Biophys Res Commun; 2007 May; 356(4):836-42. PubMed ID: 17391646
[TBL] [Abstract][Full Text] [Related]
54. Adenovirus-mediated gene transfer of growth and differentiation factor-5 into tenocytes and the healing rat Achilles tendon.
Rickert M; Wang H; Wieloch P; Lorenz H; Steck E; Sabo D; Richter W
Connect Tissue Res; 2005; 46(4-5):175-83. PubMed ID: 16546820
[TBL] [Abstract][Full Text] [Related]
55. [Osteodifferentiation of bone marrow mesenchymal stem cells after transfected by lentiviral vector mediated bone morphogenetic protein 2].
Xu S; Lin J; Liu W; Wu C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Nov; 27(11):1380-5. PubMed ID: 24501901
[TBL] [Abstract][Full Text] [Related]
56. Articular cartilage repair by genetically modified bone marrow aspirate in sheep.
Ivkovic A; Pascher A; Hudetz D; Maticic D; Jelic M; Dickinson S; Loparic M; Haspl M; Windhager R; Pecina M
Gene Ther; 2010 Jun; 17(6):779-89. PubMed ID: 20220780
[TBL] [Abstract][Full Text] [Related]
57. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy.
Turgeman G; Pittman DD; Müller R; Kurkalli BG; Zhou S; Pelled G; Peyser A; Zilberman Y; Moutsatsos IK; Gazit D
J Gene Med; 2001; 3(3):240-51. PubMed ID: 11437329
[TBL] [Abstract][Full Text] [Related]
58. Osteogenic differentiation effects on rat bone marrow-derived mesenchymal stromal cells by lentivirus-mediated co-transfection of human BMP2 gene and VEGF165 gene.
Jiang J; Fan CY; Zeng BF
Biotechnol Lett; 2008 Feb; 30(2):197-203. PubMed ID: 17896080
[TBL] [Abstract][Full Text] [Related]
59. Multiply attenuated, self-inactivating lentiviral vectors efficiently transduce human coronary artery cells in vitro and rat arteries in vivo.
Céfaï D; Simeoni E; Ludunge KM; Driscoll R; von Segesser LK; Kappenberger L; Vassalli G
J Mol Cell Cardiol; 2005 Feb; 38(2):333-44. PubMed ID: 15698840
[TBL] [Abstract][Full Text] [Related]
60. Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo.
Lou J; Xu F; Merkel K; Manske P
J Orthop Res; 1999 Jan; 17(1):43-50. PubMed ID: 10073646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
